Clinical Utility of Cytomegalovirus Cell-Mediated Immunity in Transplant Recipients With Cytomegalovirus Viremia-Reference-Cited by-同舟云学术

Clinical Utility of Cytomegalovirus Cell-Mediated Immunity in Transplant Recipients With Cytomegalovirus Viremia

Published:2012-01-27 Issue:2 Volume:93 Page:195-200
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Lisboa Luiz F.,Kumar Deepali,Wilson Leticia E.,Humar Atul

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference25 articles.

1. . Extended valganciclovir prophylaxis in DR- kidney transplant recipients is associated with long-term reduction in cytomegalovirus disease: Two-year results of the IMPACT study.;Humar;Transplantation,2010

2. . Long-term efficacy and safety of 12 months of valganciclovir prophylaxis compared with 3 months after lung transplantation: A single-center, long-term follow-up analysis from a randomized, controlled cytomegalovirus prevention trial.;Finlen Copeland;J Heart Lung Transplant,2011

3. Monitoring CMV-spezifischer T-Zellen nach Organtransplantation Monitoring of CMV-specific T-cell levels after organ transplantation.;Sester;J Lab Med,2008

4. . Cell-mediated immunity to predict cytomegalovirus disease in high-risk solid organ transplant recipients.;Kumar;Am J Transplant,2009

5. . Ex vivo monitoring of human cytomegalovirus-specific CD8 T-cell responses using QuantiFERON-CMV.;Walker;Transpl Infect Dis,2007

Cited by 123 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of cytomegalovirus in adult solid organ transplant patients: GESITRA-IC-SEIMC, CIBERINFEC, and SET recommendations update;Transplantation Reviews;2024-12

2. Cell-mediated Immunity to Guide Primary Prophylaxis for CMV Infection in Organ Transplant Recipients: A Multicenter Single-arm Prospective Study;Transplantation;2024-08-20

3. Immune Control of Human Cytomegalovirus (HCMV) Infection in HCMV-Seropositive Solid Organ Transplant Recipients: The Predictive Role of Different Immunological Assays;Cells;2024-08-08

4. Pathogen-specific cell-mediated immunity to guide the management of cytomegalovirus in solid organ transplantation: state of the art clinical review;Expert Review of Clinical Immunology;2024-07-24

5. Using a commercially available assay that measures cytomegalovirus (CMV)-specific T-cell immunity to predict protection against CMV: A prospective, blinded clinical study;Diagnostic Microbiology and Infectious Disease;2024-02